S

Sinopharm Group Co.
1099

Last Price

Income Statement

Income Statement
Metric2006200720082009201020112012201320142015201620172018201920202021202220232024LTM
CN¥596.57BCN¥584.508BCN¥575.824B
CN¥548.058BCN¥540.253BCN¥532.737B
CN¥48.512BCN¥44.255BCN¥43.088B
CN¥0MCN¥0MCN¥123.355M
CN¥26.15BCN¥25.572BCN¥25.694B
CN¥2.153BCN¥2.495BCN¥2.161B
CN¥20.209BCN¥16.188BCN¥15.108B
CN¥-2.43BCN¥-2.103BCN¥-1.595B
CN¥1.733BCN¥-0.085BCN¥0.089B
CN¥-0.697BCN¥-2.188BCN¥-1.506B
CN¥19.512BCN¥14.001BCN¥13.602B
CN¥4.502BCN¥3.577BCN¥3.75B
CN¥9.054BCN¥7.05BCN¥6.804B
CN¥2.9CN¥2.26CN¥2.18
CN¥2.9CN¥2.26CN¥2.18
CN¥3.121BCN¥3.121BCN¥6.228B
CN¥3.121BCN¥3.121BCN¥6.228B
CN¥26.899BCN¥20.175BCN¥20.582B
CN¥4.43BCN¥2.356BCN¥3.44B
CN¥22.469BCN¥17.819BCN¥17.142B

Revenue And Expenses Breakdown

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.